Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s ; volume:10 ; number:1 ; day:8 ; month:9 ; year:2022 ; pages:1-25 ; date:12.2022
Acta Neuropathologica Communications ; 10, Heft 1 (8.9.2022), 1-25, 12.2022
- Urheber
-
Toomey, Christina E.
Heywood, Wendy E.
Evans, James R.
Lachica, Joanne
Pressey, Sarah N.
Foti, Sandrine C.
Shahrani, Mesfer Al
D’Sa, Karishma
Hargreaves, Iain P.
Heales, Simon
Orford, Michael
Troakes, Claire
Attems, Johannes
Gelpi, Ellen
Palkovits, Miklos
Lashley, Tammaryn
Gentleman, Steve M.
Revesz, Tamas
Mills, Kevin
Gandhi, Sonia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-022-01424-6
- URN
-
urn:nbn:de:101:1-2022112521071827815891
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Toomey, Christina E.
- Heywood, Wendy E.
- Evans, James R.
- Lachica, Joanne
- Pressey, Sarah N.
- Foti, Sandrine C.
- Shahrani, Mesfer Al
- D’Sa, Karishma
- Hargreaves, Iain P.
- Heales, Simon
- Orford, Michael
- Troakes, Claire
- Attems, Johannes
- Gelpi, Ellen
- Palkovits, Miklos
- Lashley, Tammaryn
- Gentleman, Steve M.
- Revesz, Tamas
- Mills, Kevin
- Gandhi, Sonia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mitochondrial dysfunction in Parkinson’s disease
The genetic architecture of mitochondrial dysfunction in Parkinson’s disease
Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives
Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease
Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model
Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease
Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease
Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment
Treatment Options for Urogenital Dysfunction in Parkinson’s Disease
Mitochondrial complex I deficiency stratifies idiopathic Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease
The genetic architecture of mitochondrial dysfunction in Parkinson’s disease
Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives
Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease
Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model
Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease
Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease
Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment
Treatment Options for Urogenital Dysfunction in Parkinson’s Disease
Mitochondrial complex I deficiency stratifies idiopathic Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease
The genetic architecture of mitochondrial dysfunction in Parkinson’s disease
Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives
Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease
Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model
Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease
Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease
Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment
Treatment Options for Urogenital Dysfunction in Parkinson’s Disease